Vanflyta
Term · Oncology and biomedicine · MLC-T-ONC-009163
A drug used with certain chemotherapy drugs and then alone as maintenance therapy to treat adults with newly diagnosed acute myeloid leukemia that has a certain mutation in the FLT3 gene. It is also being studied in the treatment of other types of cancer. Vanflyta blocks FLT3 and other proteins, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called quizartinib dihydrochloride.
| Identifier | MLC-T-ONC-009163 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | quizartinib dihydrochloride |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-009163",
"term": "Vanflyta",
"field": "Oncology and biomedicine",
"definition": "A drug used with certain chemotherapy drugs and then alone as maintenance therapy to treat adults with newly diagnosed acute myeloid leukemia that has a certain mutation in the FLT3 gene. It is also being studied in the treatment of other types of cancer. Vanflyta blocks FLT3 and other proteins, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called quizartinib dihydrochloride.",
"synonyms": [
"quizartinib dihydrochloride"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/vanflyta/"
}
Record 17,105 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.